Smart watches and devices are making more people aware of their irregular heartbeats. In fact, in some cases, they are leading to a common condition being diagnosed sooner: Atrial Fibrillation, ...

The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, thus enabling researchers to use ...

Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...

As the use of wearable technology grows, smart watches are marketed across the globe to consumers as a way to monitor health. For some, they’re told by these devices that they have atrial fibrillation ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Symptom-driven electrocardiogram (ECG) recording plays a significant role in the detection of ...

Steven Deitelzweig, MD, system chairman of hospital medicine at Ochsner Clinical School, professor of medicine at the University of Queensland, discusses key findings from a recent study on the ...

Pulsed field ablation (PFA) has been embraced as a catheter ablation modality with potential to be safer for atrial fibrillation (Afib, or AF) treatment due to its tissue-selective mechanism of cell ...

A new survey finds nearly two‑thirds of Americans use smartwatches or other devices to track heart health, but only 1 in 4 ...

AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial ...

ETHealthworld.com brings latest atrial fibrillation news, views and updates from all top sources for the Indian Health industry.